Strategy
MSTR
MARA Holdings
MARA
Riot Platforms
RIOT
Rumble
RUM
Trump Media & Technology
DJT
Metacrine Inc is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases. Its program targets the farnesoid X receptor, or FXR, which is central to modulating liver and GI diseases. Its FXR product candidates include MET409 and MET642.